Jpmorgan Chase Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jpmorgan chase co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jpmorgan Chase Co Today - Breaking & Trending Today

Editas Medicine (NASDAQ:EDIT) Trading Up 14.2%

Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) shares were up 14.2% during trading on Wednesday . The company traded as high as $6.20 and last traded at $6.20. Approximately 1,553,016 shares traded hands during mid-day trading, a decline of 16% from the average daily volume of 1,845,939 shares. The stock had previously closed at […] ....

Jessica Hopfield , Gilmore Neil Oneill , Morgan Stanley , Deutsche Bank , Swiss National Bank , Jpmorgan Chase Co , Editas Medicine Inc , Russell Investments Group Ltd , Securities Exchange Commission , Editas Medicine , Get Free Report , Neilo Neill , Exchange Commission , Director Jessica Hopfield , National Bank , Investments Group , Leber Congenital Amaurosis , Editas Medicine Daily ,

Editas Medicine (NASDAQ:EDIT) Trading Up 14.2%

Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) shares were up 14.2% during trading on Wednesday . The company traded as high as $6.20 and last traded at $6.20. Approximately 1,553,016 shares traded hands during mid-day trading, a decline of 16% from the average daily volume of 1,845,939 shares. The stock had previously closed at […] ....

Jessica Hopfield , Gilmore Neil Oneill , Deutsche Bank , Morgan Stanley , Securities Exchange Commission , Russell Investments Group Ltd , Jpmorgan Chase Co , Swiss National Bank , Editas Medicine Inc , Editas Medicine , Get Free Report , Neilo Neill , Exchange Commission , Director Jessica Hopfield , National Bank , Investments Group , Leber Congenital Amaurosis , Editas Medicine Daily ,

Royalty Pharma plc (NASDAQ:RPRX) Stake Raised by Aurora Investment Counsel

Aurora Investment Counsel boosted its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 7.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 40,558 shares of the biopharmaceutical company’s stock after acquiring an additional 2,656 shares during the quarter. […] ....

United States , Goldman Sachs Group , Norges Bank , Jpmorgan Chase Co , Exchange Commission , Morgan Stanley , Vanguard Group Inc , Aurora Investment Counsel , Royalty Pharma , Free Report , Investment Counsel , Capital Partners , Get Free Report , Royalty Pharma Daily ,